Pharmaceutical - Global Strategy

Global Strategy

Kowa globally researches, develops, and markets prescription drugs, medical devices, OTC drugs, and healthcare products through its offices and affiliated companies in the United States, Europe, and Asia. We are committed to ensuring the steady supply of products with quality and reliability to the countries around the world to help their people enjoy better health and improved quality of life.

Prescription Drugs
We are expanding our prescription drug business, focusing on cardiovascular and ophthalmologic fields. Our portfolio includes, our key product LIVALO, which is highly recognized as treatment for hypercholesterolemia both in Japan and internationally, PARMODIA for hyperlipidemia treatment, a glaucoma and ocular hypertension treatment agent GLANATEC, and others.

Medical Devices
We market AVANSEE intraocular lenses for cataract treatment and medical devices for ophthalmology in Japan and many countries around the world, contributing to the advancement in ophthalmic treatment.

Self-Care Products
VANTELIN is a trusted brand in Japan with a growing global presence. Our portfolio includes topical anti-inflammatory analgesics for joint and muscle pain, as well as braces and support products that help people stay active in their daily lives. We continue to expand the brand globally—particularly in Asia—with a focus on improving quality of life.